Stock Track | CSPC Pharmaceutical Shares Plummet After Profit Warning

Stock Track11-01

Shares of CSPC Pharmaceutical Group Ltd. plummeted as much as 13% on Thursday, marking the biggest one-day drop since August 22nd. The steep decline was triggered by the company's warning of a projected 16% year-over-year decrease in net profit for the nine months ended September 2024.

According to CSPC Pharmaceutical Group, the decline in profit is attributed to dwindling revenue from its finished drugs business in key therapeutic areas like oncology, cardiovascular, and nervous system treatments. The implementation of volume-based procurement by hospitals has negatively impacted sales in these crucial segments.

With a current market capitalization of around HK$61.4 billion ($7.88 billion), CSPC Pharmaceutical's stock hit a low of HK$5 during trading, the lowest level since September 23rd. The sell-off contrasted with the broader market trend, as the Hang Seng Commerce & Industry Index climbed 1%, the healthcare index rose 0.7%, and the Hang Seng Index increased by 1% during the same trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1102070005?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-01 17:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102070005","market":"hk","top_or_hot":-1,"title":"Stock Track | CSPC Pharmaceutical Shares Plummet After Profit Warning","media":"Stock Track","content":"<p>Shares of CSPC Pharmaceutical Group Ltd. plummeted as much as 13% on Thursday, marking the biggest one-day drop since August 22nd. The steep decline was triggered by the company's warning of a projected 16% year-over-year decrease in net profit for the nine months ended September 2024.</p>\n\n<p>According to CSPC Pharmaceutical Group, the decline in profit is attributed to dwindling revenue from its finished drugs business in key therapeutic areas like oncology, cardiovascular, and nervous system treatments. The implementation of volume-based procurement by hospitals has negatively impacted sales in these crucial segments.</p>\n\n<p>With a current market capitalization of around HK$61.4 billion ($7.88 billion), CSPC Pharmaceutical's stock hit a low of HK$5 during trading, the lowest level since September 23rd. The sell-off contrasted with the broader market trend, as the Hang Seng Commerce & Industry Index climbed 1%, the healthcare index rose 0.7%, and the Hang Seng Index increased by 1% during the same trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | CSPC Pharmaceutical Shares Plummet After Profit Warning</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | CSPC Pharmaceutical Shares Plummet After Profit Warning\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-01 17:54 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of CSPC Pharmaceutical Group Ltd. plummeted as much as 13% on Thursday, marking the biggest one-day drop since August 22nd. The steep decline was triggered by the company's warning of a ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01093","symbol_name":"石药集团","start_time":0,"source_url":"","article_id":"1102070005","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102070005","pubTimestamp":1730454868,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of CSPC Pharmaceutical Group Ltd. plummeted as much as 13% on Thursday, marking the biggest one-day drop since August 22nd. The steep decline was triggered by the company's warning of a projected 16% year-over-year decrease in net profit for the nine months ended September 2024.According to CSPC Pharmaceutical Group, the decline in profit is attributed to dwindling revenue from its finished drugs business in key therapeutic areas like oncology, cardiovascular, and nervous system treatment","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01093":"石药集团"},"translate_title":"股票赛道石药集团盈利预警后股价暴跌","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01093":1},"content_text":"Shares of CSPC Pharmaceutical Group Ltd. plummeted as much as 13% on Thursday, marking the biggest one-day drop since August 22nd. The steep decline was triggered by the company's warning of a projected 16% year-over-year decrease in net profit for the nine months ended September 2024.\nAccording to CSPC Pharmaceutical Group, the decline in profit is attributed to dwindling revenue from its finished drugs business in key therapeutic areas like oncology, cardiovascular, and nervous system treatments. The implementation of volume-based procurement by hospitals has negatively impacted sales in these crucial segments.\nWith a current market capitalization of around HK$61.4 billion ($7.88 billion), CSPC Pharmaceutical's stock hit a low of HK$5 during trading, the lowest level since September 23rd. The sell-off contrasted with the broader market trend, as the Hang Seng Commerce & Industry Index climbed 1%, the healthcare index rose 0.7%, and the Hang Seng Index increased by 1% during the same trading session.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1102070005"}